2026-09-21T10:34:53Zhttps://digital.library.adelaide.edu.au/server/oai/request

oai:digital.library.adelaide.edu.au:2440/185472015-03-10T03:44:46Zcom_2440_14759col_2440_14760

Baker, Paul Wayne Dept. of Physiology 1995 http://hdl.handle.net/2440/18547 Bibliography :leaves 149-172. vii, 172,[60] leaves : ill. ; 30 cm. The investigations centre on the use of [beta]-aminothiols (cysteine, cysteamine and penicillamine) to decrease endogenous oxalate production by forming adducts with glyoxylate, the immediate precursor of oxalate. They indicate that cysteine delivery drugs like OTC have the potential to aid in management of calcium oxalate stone disease, thereby reducing endogenous oxalate production and urinary oxalate excretion. Thesis (Ph.D.)--University of Adelaide, Dept. of Physiology, 1995? 544020 bytes application/pdf en 616.622 20 Calcium oxalate Metabolism. Urinary organs Calculi. Bladder Calculi. Drugs, Nonprescription Utilization. [Beta]- aminothiols and the regulation of hepatic oxalate production / Paul Wayne Baker. Thesis This electronic version is made publicly available by the University of Adelaide in accordance with its open access policy for student theses. Copyright in this thesis remains with the author. This thesis may incorporate third party material which has been used by the author pursuant to Fair Dealing exception. If you are the author of this thesis and do not wish it to be made publicly available or If you are the owner of any included third party copyright material you wish to be removed from this electronic version, please complete the take down form located at: http://www.adelaide.edu.au/legalsopen.access